TARDBP and amyotrophic lateral sclerosis: Inhibition of MMP9 was beneficial in a mutant SOD1G93A model for ALS, using the same MMP9 inhibitor we used here22, and a TDP-43 based mouse model for sporadic ALS23, suggesting MMP9 as a therapeutic target.